Abstract
Interest in neuromuscular disorders has grown rapidly in recent years as knowledge of their molecular basis has advanced and the search for potential treatment by gene or cell therapy has begun. (Allamand et al. 2000; Cordier et al. 2000; Dressman et al. 2002; Yakota et al. 2009). This chapter gives an overview of the epidemiologic, clinical, and laboratory studies of muscular dystrophies (MDs) and myopathies reported in Arab communities.